www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News US FDA chief resigns, Bush picks replacement     EU gives up attempt to refer Iran's case     EU gives up attempt to refer Iran's case    Flood water breaches levee in New Orleans again    US bus fire kills 20 hurricane evacuees    Trading prices between non-US dollar currencies, yuan more fluctuating    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Online marketplace of Manufacturers & Wholesalers
   News Photos Voice People BizChina Feature About us   
US FDA chief resigns, Bush picks replacement
www.chinaview.cn 2005-09-24 09:47:55

    
US Food and Drug Administration (FDA) Commissioner Lester Crawford tendered his resignation on Friday, and President George W. Bush immediately announced his intention to name Andrew von Eschenbach to take his place.
Lester Crawford (Yahoo photo)
WASHINGTON, Sept. 23 (Xinhuanet) -- US Food and Drug Administration (FDA) Commissioner Lester Crawford tendered his resignation on Friday, and President George W. Bush immediately announced his intention to name Andrew von Eschenbach to take his place.

    Crawford's resignation took effect immediately, and it was not known why he chose to leave less than three months after he was confirmed for the job.

    Crawford, who had worked in the agency on four separate occasions over 30 years, was confirmed by the Senate after servingas a longtime deputy and acting commissioner, when Health and Human Services Secretary Mike Leavitt assured Senate Democrats the FDA would act on over-the-counter sales of the morning after pill Plan B by Sept. 1.

    Crawford was under fresh attack in late August when the FDA indefinitely postponed a ruling on whether Barr Pharmaceuticals Inc. could sell the Plan B contraceptive without a prescription.

    Bush asked Eschenbach, director of the National Cancer Institute, to serve as acting FDA commissioner, the White House said in a statement.

    Bush intended to "designate Andrew von Eschenbach, of Texas, tobe acting commissioner of Food and Drugs at the Food and Drug Administration at the Department of Health and Human Services," the statement said. Enditem

  Related Story
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.